Free National NPI Number Registry
Kian Eftekhari
Home > Kian Eftekhari
NPI Number Detailed Information
Provider Information:
| Name: | Kian Eftekhari |
| Gender: | M |
| Provider License Number If Given: | 2016-01582 |
NPI Information:
| NPI: | 1689991747 |
| Entity Type (Individual or Organization): |
1-ind |
| Enumeration Date: | 4/29/2010 |
| Last Update Date: | 10/5/2019 |
| Reputation Report: |
Provider Business Mailing Address:
| Address: | 1644 E LAIRD AVE Salt Lake City, UT 84105 |
| Phone Number: | |
| Fax Number: |
Provider Business Practice Location Address:
| Address: | EYELID CENTER OF UTAH 22 S 900 E Salt Lake City, UT 84102 |
| Phone Number: | 8016853398 |
| Fax Number: |
Provider Taxonomy:
| Primary: | 207WX0200X |
| Secondary (if any): | 207W00000X |
| State: | UT |
Top Doctors in UT
About Kian Eftekhari
Kian Eftekhari ( KIAN EFTEKHARI ) is A Ophthalmology Physician in Salt Lake City, UT.
The NPI Number for Kian Eftekhari is 1689991747.
The current location address for Kian Eftekhari is EYELID CENTER OF UTAH 22 S 900 E Salt Lake City, UT 84102 and the contact number is and fax number is .
The mailing address for Kian Eftekhari is 1644 E LAIRD AVE Salt Lake City, UT 84105- 8016853398 (mailing address contact number - ).
A physician who specializes in oculofacial plastic and reconstructive surgery. This subspecialty combines orbital and periocular surgery with facial plastic surgery, and includes aesthetic and reconstructive surgery of the face, orbit, eyelid, and lacrimal system. Practitioners evaluate, diagnose and treat conditions involving the eyelids, brows, midface, orbits, lacrimal systems and surrounding and supporting structures of the face and neck.
Provider Business Location on Map
FAQs:
What is the NPI Number for Kian Eftekhari ?
Answer: The NPI Number for Kian Eftekhari is 1689991747
Where is Kian Eftekhari located?
Answer: Kian Eftekhari is located at EYELID CENTER OF UTAH 22 S 900 E Salt Lake City, UT 84102.
What is the specialty for Kian Eftekhari ?
Answer: The Specialty of Kian Eftekhari is A Ophthalmology Physician.
Are there any online reviews for Kian Eftekhari ?
Answer: Yes! Check It Now.
Are there any other health care providers in Salt Lake City, UT?
Answer: Yes, there are given below...
Medicare Physician & Other Practitioners
Information on services and procedures provided to Original Medicare (fee-for-service) Part B (Medical Insurance) beneficiaries by Kian Eftekhari
Medicare Part D Prescribers
Information on prescription drugs provided to Medicare beneficiaries enrolled in Part D (Prescription Drug Coverage), by physicians and other health care providers, aggregated by provider.
| Provider Specialty Type | Ophthalmology |
| Source of Provider Specialty | |
| Number of Medicare Part D Claims, Including Refills | 179 |
| Number of Standardized 30-Day Fills | 184.93333333 |
| Aggregate Cost Paid for All Claims | 3601.44 |
| Number of Day's Supply for All Claims | 2238 |
| Number of Medicare Beneficiaries | 75 |
| Number of Claims, Including Refills, for Beneficiaries Age 65+ | 160 |
| Including Refills, for Beneficiaries Age 65+ | 163.6 |
| Beneficiaries Age 65+ | 3299.23 |
| Number of Day's Supply for All Claims for Beneficaries Age 65+ | 1951 |
| Number of Medicare Beneficiaries Age 65+ | |
| Reason for Suppression of Brnd_Tot_Clms and Brnd_Tot_Drug_Cst | |
| Total Claims of Brand-Name Drugs | 29 |
| Reason for Suppression of Gnrc_Tot_Clms and Gnrc_Tot_Drug_Cst | |
| Total Claims of Generic Drugs, Including Refills | 150 |
| Aggregate Cost Paid for Generic Drugs | 2211.92 |
| Reason for Suppression of Othr_Tot_Clms and Othr_Tot_Drug_Cst | |
| Total Claims of Other Drugs, Including Refills | 0 |
| Aggregate Cost Paid for Other Drugs | 0 |
| Reason for Suppression of MAPD_Tot_Clmsand MAPD_Tot_Drug_Cst | |
| Number of Claims for Beneficiaries Covered by MAPD Plans | 95 |
| Aggregate Cost Paid for Claims Filled by Beneficiaries in MAPD Plans | 2572.31 |
| Reason for Suppression of PDP_Tot_Clms and PDP_Tot_Drug_Cst | |
| Number of Claims for Beneficiaries Covered by Standalone PDP Plans | 84 |
| Aggregate Cost Paid for Claims Filled by | 1029.13 |
| Reason for Suppression of LIS_Tot_Clms and LIS_Drug_Cst | |
| Number of Claims for Beneficiaries Covered by Low-Income Subsidy | 34 |
| Aggregate Cost Paid for Claims Covered by Low-Income Subsidy | 965.8 |
| Reason for Suppression of NonLIS_Tot_Clms and NonLIS_Drug_Cst | |
| Number of Claims for Beneficiaries Not Covered by Low-Income Subsidy | 145 |
| by Low-Income Subsidy | 2635.64 |
| Total Claims of Opioid Drugs, Including | 11 |
| Aggregate Cost Paid for Opioid Drugs | 42.33 |
| Opioid Claims | |
| Opioid_Tot_Clms divided by the Tot_Clms | 6.1452513966 |
| Total Claims of Long-Acting Opioid Drugs | 0 |
| Aggregate Cost Paid for Long-Acting Opioid | 0 |
| Number of Day's Supply of All Long-Acting | 0 |
| Long-Acting Opioid Claims | |
| Opioid_LA_Tot_Clms divided by the | 0 |
| Total Claims of Antibiotic Drugs, Including | |
| Aggregate Cost Paid for Antibiotic Drugs | |
| Antibiotic Claims | |
| Reason for Suppression of Antpsyct_GE65_Tot_Clms and Antpsyct_GE65_Tot_Drug_Cst | |
| Including Refills, for Beneficiaries Age 65+ | 0 |
| Aggregate Cost Paid for AntipsychoticDrugs for Beneficiaries Age 65+ | 0 |
| Reason for Suppression of Antpsyct_GE65_Tot_Benes | |
| Number of Medicare Beneficiaries Age 65+Filling Antipsychotic Claims | |
| Average Age of Beneficiaries | 71.413333333 |
| Number of Beneficiaries Age Less Than 65 | |
| Number of Beneficiaries Age 65 to 74 | |
| Number of Beneficiaries Age 75 to 84 | |
| Number of Female Beneficiaries | 47 |
| Number of Male Beneficiaries | 28 |
| Number of Non-Hispanic White | 65 |
| Number of Black or African American | 0 |
| Number of Asian Pacific Islander | |
| Number of Hispanic Beneficiaries | |
| Number of American Indian/Alaskan NativeBeneficiaries | |
| Number of Beneficiaries with Race Not | |
| Only Entitlement | 64 |
| Average Hierarchical Condition Category | 1.03911074 |
More Providers in salt-lake-city , ut
kian eftekhari in Other Directories
Provider don't have other directory link yet.
